November 02, 2015
1 min read
Save

Two-level, three-level ACCF for cervical spondylotic myelopathy offer similar results

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Despite having a higher estimated blood loss, two-level anterior cervical corpectomy and fusion offers similar results in the treatment of cervical spondylotic myelopathy compared to three-level anterior cervical discectomy and fusion, according to the results in a recently published study.

Researchers analyzed 20 patients who underwent two-level anterior cervical corpectomy and fusion (ACCF) and 35 patients who underwent three-level anterior cervical discectomy and fusion for cervical spondylotic myelopathy between 2006 and 2012. All procedures were performed by one or two surgeons.

Patients in the two-level ACCF group had more estimated blood loss in their procedures and a longer hospital stay compared with three-level ACDF (7.2 days vs. 4.9 days, P = .048), but a subgroup of patients without posterior spinal fusion were found to have similar length of stays (3.1 days for ACCF vs. 4.4 days for ACDF, P = 0.267).

Researchers noted the postoperative sagittal Cobb angles were statistically similar between the two groups, with the mean angle in the ACCF group at 7.2° compared to 12.1° for the ACDF group (P = .173).

Additionally, both groups experienced similar postoperative cervical lordosis, pain relief, neurological improvements, radiographic pseudarthrosis rates and operative adjacent-segment disease rates, according to the study data.

Researchers concluded that except for blood loss, both two-level ACCF and three-level ACDF had similar postoperative outcomes when posterior spinal fusion was not involved. – by Robert Linnehan

Disclosures: Lau reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.